As concerns persist over the quality of medicines made in Asia, a recent episode involving Strides Pharma, one of the largest purveyors of generic drugs, illustrates the extent of the problem.

A week before a Food and Drug Administration investigator arrived at a facility in Puducherry, India, the company had discarded documents, including batch records, in a 55-gallon drum in its scrapyard. “Multiple bags” of documents pertaining to drug productions, quality, and laboratory operations were “awaiting shredding,” according to a July 1 warning letter posted this week on the agency web site.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • After the countless articles about the topic of dangerously toxic medications being the very first to destroy our lives with bogus information and serious issues about the production of unsafe conditions that exist in places like the Auribindo site, I am disinclined to use any medical generics from any other serious health issues that are complicit with the distribution from the India locations for obtaining any medicine that is unfit for human and animal consumption. The pharmacy manager where I purchase my few medical requirements is honest about this topic that I am opposed to this using anything that is located in most of India’s manufacturing of toxic products unfit for consumption, and I am fortunate to have an ethical pharmacist who is truthful about this life threatening situation. Ask before you have your prescriptions that are purchased from, and the cleanliness of the pharmaceutical companies from which they were produced.

    When we all stop paying for our own health decline, maybe then our combined experiences of not choosing these life threatening medications from any other pharmaceutical companies from places like we get from the companies in India.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy